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Background: Adenovirus co-infections in HIV patients cause wide-spread morbidity in sub-Saharan Africa, but little
research has documented the burden and distribution of these pathogens. This study was conducted between
December, 2010 and March, 2011 to investigate the prevalence of Adenovirus Respiratory Tract and HIV co-infections in
Patients attending the University of Ilorin Teaching Hospital Ilorin, Nigeria.
Method: One Hundred and Eighty Four (184) patients were recruited with confirmed HIV positive status. Investigation
was done by serology using the Human Adenovirus IgG ELISA Kit to test for the presence of the Immunoglobulin G
(antibody) against the virus. This was conducted and juxtaposed simultaneously with responses received from
the questionnaires provided to each participant to correlate the relationship of the co-infections to their socio-
demographic factors (Age, Gender, Occupation and location of residence), risk factors (Average hours of exposure
per day (time spent outdoor daily), proximity of their apartments to livestock settlements), recent occurrence of
respiratory tract infections/conjunctivitis and their ART status.
Results: This study recorded a prevalent rate of 38% (70 patients) to the co-infections. Nevertheless, 62% (114 patients)
tested negative to the co-infections.
Conclusion: There was statistical significance between the ages of HIV patients and Adenovirus co-infection (p < 0.05).
However, there was no significance with respect to gender of the subjects (p > 0.05). The findings also showed that
there were statistical significance for all the risk factors; Occupation, Location and Proximity to Livestock settlement,
recent respiratory tract infection/conjunctivitis, and ART status in relation to Adenovirus and HIV co-infections
(p < 0.05).
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Adenoviruses belong to the family Adenoviridae which is
a group 1 double-stranded DNA virus according to the
Baltimore Classification Scheme of Viruses. A typical
adenovirus measures 70-90nm possessing an icosahedral
capsid [1]. It was first isolated in the 1950’s in adenoid
tissue-derived cell cultures, giving rise to the name
(Adenovirus). In humans, there are 56 accepted human* Correspondence: tomak74@yahoo.com
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unless otherwise stated.adenovirus types (HAdV-1 to 56) in seven species (Hu-
man Adenovirus A to G) [2].
According to Ampel in 2008, in New Mexico; three
cases of severe acute respiratory tract infection were re-
ported, one of which resulted in death, these were associ-
ated with adenovirus 14 (Ad14). Another report by [3]
tagged Ad14 serotype as an emerging cause of acute re-
spiratory disease among US military recruits in 2005. Fur-
thermore, from March through June 2007, One Hundred
and Forty (140) additional cases were confirmed in the
United States [3].
Unlike Adenovirus, HIV is a member of the genus
Lentivirus part of the family of Retroviridae. Lentiviruses
have many common morphologies and peculiar biologicalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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viruses. It is roughly spherical with a diameter of about
120 nm, around 60 times smaller than a red blood cell [4].
HIV infection in humans is considered a pandemic by
the World Health Organization (WHO). HIV progressively
causes acquired immunodeficiency syndrome (AIDS) [5,6].
This is a condition in humans in which the immune sys-
tem falls, leading to life-threatening infections which are
called opportunistic infections caused by other pathogenic
organisms.
HIV was discovered in 1981 and till date, AIDS has
killed more than 25 million people [7]. The virus infects
about 0.6% of the world’s population. In 2005, AIDS
claimed an estimated 2.4–3.3 million lives, of which more
than 570,000 were children. About One third of these
deaths occurred in Sub-Saharan Africa, where poor
economic growth and poor standard of living was on
the increase [8]. During this time, HIV was statistically
predicted to infect 90 million people in Africa, which
would result in a minimum estimate of 18 million orphans
from this crisis [9]. Antiretroviral treatment reduces both
the mortality and the morbidity of HIV infection. Routine
access to antiretroviral medication in developing and
under-developed countries which was unaffordable in the
past has been aided by international Organizations.
Although, adenovirus infection is typically self-limiting,
fatal disease may occur among persons infected with Hu-
man Immunodeficiency Virus (HIV) and other immuno-
suppressed individuals [10]. Among immunosuppressed
persons, adenovirus infection is frequently associated with
disseminated disease in which two or more organs are in-
volved; viremia is frequently present [10].
Mortality for persons with disseminated adenovirus dis-
ease remains high despite the use of antiviral therapy [11].
Asymptomatic carriage of adenovirus is common in HIV-
infected persons [12]; asymptomatic viruria occurs in up
to 20% of persons with HIV/AIDS [13]; and asymptomatic
adenoviremia has been reported in children who are HIV-
seropositive [12].
Adenovirus infections occur in 12% to 28% of HIV-
infected persons, and 45% of the infections result in death,
typically within 2 months of diagnosis [14,15]. Mortality is
usually related to site of infection: and was noticed to be
60% in those with pneumonia and 50% in those with
hepatitis [14]. Most patients with AIDS and adenovirus in-
fection are co-infected with other pathogens or have other
complicating conditions that may contribute to their mor-
tality risk [16]. Adenovirus is used as a vehicle to adminis-
ter targeted therapy in the form of recombinant DNA or
protein [17].
According to [18] the average life expectancy of an HIV
infected individual was observed to be 32 years from the
time of infection if treatment is started when the CD4
count is 350/μL. Life expectancy is further enhanced ifantiretroviral therapy is initiated before the CD4 count
falls below 500/μL.
The impact of this study borders on the evaluation and
reduction of adenovirus respiratory tract co-infections in
HIV patients in the Ilorin Metropolis and its environs.
Since there is no scientifically documented data on the
epidemiology of the co-infections in Nigeria, it could serve
as a reference point for the innovation and implementa-
tion of certain management schemes that will help better
the lots of HIV/AIDS patients and the society at large.
Methods
Study site and design
This study was carried out at the Antiretroviral Therapy
Clinic of the University of Ilorin Teaching Hospital, Ilorin,
Kwara State, Nigeria. The facility is been supported by a
non-indigenous, non-governmental organization – Insti-
tute of Human Virology, Nigeria (IHVN) in collaboration
with the Hospital to provide adequate and intensive
healthcare services to HIV positive patients both within
the Ilorin metropolis and its environs. The research was
conducted between December, 2010 to March 2011. The
study was a cross-sectional descriptive research in which
the individual’s current disease status was ascertained.
Sample size of 184 patients recruited was determined by
the Fisher’s method [19].
Ethical clearance
An ethical clearance was obtained from the Medical Ad-
visory Committee of the University of Ilorin Teaching
Hospital for this research. The patients were adequately
briefed about the purpose and benefits of the study and
their consent was sought for before inclusion in the study.
They were assured that any information arising from the
study will be confidential. A follow – up counselling was
provided to the patients after the test.
Questionnaire
Instrument was administered through semi-structured
close-ended questionnaires to determine the socio-
demographic and risk factors associated with Adenovirus
co-infections with HIV. Questions were translated into
local languages or explained to the patients where neces-
sary (Additional file 1).
Enzyme linked immunosorbent assay (ELISA)
ELISA was done using the Human Adenovirus IgG
(ADV-IgG) ELISA kit (Cusabio Biotech Co.Ltd, China).
Those found positive were confirmed by rapid and sim-
ple assays [20].
Sample collection
Blood samples, 3–5 ml were collected aseptically by
ante-cubital venipuncture from patients, after obtaining
Table 1 Prevalence of adenovirus co-infections in HIV
patients with respect to age, gender, recent occurrence
of respiratory tract infections, conjunctivitis and ART
status of patients
Characteristics Positive Negative p value
Total (%) 70 (38) 114 (62)
Age group (yrs) p < 0.05
5-12 (%) 4 (66.7) 2 (33.3)
13-19 (%) 4 (66.7) 2 (33.3)
20-27 (%) 2 (33.3) 4 (66.7)
28-39 (%) 32 (30.8) 72 (69.2)
40-49 (%) 16 (47.1) 18 (52.9)
50-59 (%) 12 (42.9) 16 (57.1)
70 114
Gender p > 0.05
Male 28 (48.3) 30 (51. 7)
Female 42 (33.3) 84 (66.7)
History of recent occurrence of respiratory tract
infections
p < 0.05
Yes 16 (38.1) 26 (61. 9)
No 54 (38) 88 (62)
Conjunctivitis p < 0.05.
Yes 6 (33.3) 12 (66.7)
No 64 (38.3) 102 (61.4)
Art status p < 0.05
ART 60 (37.5) 98 (62.5)
Non ART 10 (38.5) 16 (61.5)
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samples collected after centrifugation at 2500 g were
stored at −4°C until the assays were performed.
Assay procedure
Sera samples were diluted and tested according to the
Kit’s specification and manufacturer’s instructions.
Data analysis
Statistical Package for Social Sciences Version 17.0 (SPSS
Inc., Chicago, IL) was used for all analyses. Descriptive sta-
tistics such as Standard Deviation, Frequency counts and
Percentages were used in the computing of the results in
order to give a lucid representation of the data analysed.
The Chi-square (X2) test was used to test for significant
differences and effects at p < 0.05. Results were also pre-
sented in tables and charts.
Results
The prevalence rate of Adenovirus co-infections with
HIV in the patients was observed to be 66.7% in the age
group of 5-12years and age group of 13-19years simul-
taneously having the highest prevalence rate. However, it
was 30.8% in age group (28–39 years) being the group
with the lowest prevalence rate. The overall total popula-
tion of patients having Adenovirus co-infections with
HIV was 70 accounting for 38% prevalence, while the
rest (114) tested negative to Adenovirus while being
positive for HIV infections (Table 1). There was statis-
tical significance between the ages of HIV patients and
Adenovirus co-infections.
The prevalence of Adenovirus infection in the HIV pa-
tients with respect to their gender was noticed to be
higher in males than females, with males accounting for
49%, while the females 33%. There was no significant
difference between the gender of HIV patients and
Adenovirus co-infections (p > 0.05) (Table 1).
Results also showed that the total number of HIV pa-
tients employed which tested positive to the Adenovirus
co-infections was 58 (31.5%) consisting of 38 (20.7%)
Artisans and 20(10.8%) Civil Servants. Eight (8) HIV pa-
tients were unemployed having the Adenovirus co-
infection, while four (4) HIV patients were students
having the Adenovirus co-infections (Figure 1). The
findings showed that there was significant difference
between the occupational grouping of HIV patients and
Adenovirus co-infections (p < 0.05).
The location of residence of patients was classified
majorly into two groups; Urban and Rural settlements.
The prevalence rate recorded in the urban settlers was
slightly higher (39%) than what was recorded among the
rural settlers (33%) (Figure 2). The p-value showed that
there was significant difference between the locations ofresidence in HIV patients for both urban and rural
dwellers, with Adenovirus co-infections (p < 0.05).
Prevalence rate of Adenovirus infection in HIV patients
in relation to history of recent occurrence of respiratory
tract infections (considering common symptoms such as
cough, catarrh, sore throat and sneezing) with conjunctiv-
itis noticed within 1-2weeks before visit to the clinic re-
vealed that 12.5% of the total number of Adenovirus
positive HIV patients had recent occurrences of respira-
tory tract infections and conjunctivitis before their visit to
the clinic. However, 15% of all the Adenovirus negative
HIV patients had the occurrence of both RTI and con-
junctivitis (Table 1). The p-value revealed that there was
significance difference between history of recent occur-
rence of Respiratory Tract Infections and Conjunctivitis
with Adenovirus co-infections in HIV patients (p < 0.05).
The total number of patients with their residence close
to livestock settlements was eight (8) of which 50% were
positive to Adenovirus co-infections while the remaining
50% were negative (Figure 2). Also, classification was
evaluated by correlating the average hours of exposure
per day with the frequency of Adenovirus co-infection
occurrence in the patients. The data obtained from this
Figure 1 Adenovirus infection prevalence rate in HIV patients by occupational grouping. The p-value showed that there was significant
difference between the Occupational grouping of HIV patients and Adenovirus co-infections (p < 0.05).
Figure 2 The prevalence of adenovirus co-infection in the HIV patients categorized by their locations and proximity of residence to
livestock settlement. The p-value showed that there was significant difference between the locations and the proximity of the HIV Patients’
residence to Livestock Settlement with Adenovirus co-infection (p < 0.05).
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hours of exposure group and 9–14 hours are represented
in Figure 3. The class having the highest prevalence in
both cases was the 28-39years age bracket. It accounted
for 46.2% of cases across the age groups for the category
of 5–8 hours exposure and 47.4% in the 9-14hours cat-
egory. The p-values showed that there was no significant
difference between the ages and Hours of daily exposure
of HIV patients with Adenovirus co-infection for both
5–8 hours and 9–13 hours exposure (p > 0.05).
The percentage of the total population of ART patients
positive to Adenovirus infection is 38%. Also, of all the 26
Non-ART patients, only 10 (38.5%) were positive to
Adenovirus co-infections (Table 1). The p-value showed
that there was significant difference between the ART
status of HIV patients and Adenovirus co-infections
(p < 0.05).
Discussion
The Prevalence of Adenovirus co-infections in HIV pa-
tients in relation to age revealed a high prevalence rate
among children within the school age (5–12 years). Chil-
dren are at high risk of infection due to their frequent
and consistent contact with carriers of the Adenoviral
pathogen, their immune status which has already been
suppressed with the Human Immunodeficiency Virus, is
usually not well developed to ward off the Adenovirus
infection. This is in line with the work of [21] which re-
ported that ‘Adenovirus infection typically affects childrenFigure 3 Prevalence of adenovirus infections in HIV patients by age-m
by patients’ exposure rate. The p-value showed that there was no signif
Patients with Adenovirus co-infection (p > 0.05).from infancy to school age, but children of any age may be
affected, including neonates. Young adults (13–19 years)
in any setting of close quarters and stress may be affected.
A study on Adenovirus involvement in diarrhoea in Chil-
dren from the Northwestern part of Nigeria by [22] re-
ported a relatively high prevalence rate for the same age
group.
The gender classification in the prevalence study of
Adenovirus infection in HIV patients was noted to be
higher in males than it occurred in females. This is in
tandem with the work of [21] submitting therein that
Adenovirus urinary tract infections are more common
in males. The prevalence of other syndromes does not
appear to be affected by the sex of the individual. In
their work, Aminu and Colleagues recorded a higher
prevalence of enteric adenovirus infection in males than
in females children-patients [22]. The high prevalence
noticed in the male gender could be largely dependent
on the behavioural disposition of male patients to ortho-
dox medicine and unwillingness to consult healthcare
facilities for medical attention. One major problem associ-
ated with the provision of healthcare services in Nigeria
and some parts of Africa as portrayed by [23] was lack of
education.
Considering the occupation of patients, the highest
prevalence of Adenovirus was noticed among the Artesans
and Civil Servants, with the Artesan group having the
overall highest prevalence, except in the age group 40–49
where the prevalence in civil servants was higher than thatatching with respect to the various categories of classification
icant difference between the ages and Hours of daily exposure of HIV
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volvement in tasks that are associated with high rate of ex-
posure. In 2007, a United States Air force training facility
reported a cluster of severe respiratory tract illnesses asso-
ciated with Ad14, which was tagged “a rare Human
Adenovirus serotype”, it caused a protracted outbreak of
respiratory illness among military recruits [24]. In a report
from Zealand on Municipal Sewage Treatment (MST),
where farms were said to be close to MST sites, farmers
may most likely be at high risk of viral infections in cases
of epidemic outbreak. Most often, people in the 28–39
and 40–49 years in this region are prone to occupational
hazards with high risk of contracting the infection [25].
However, an observed low prevalence of Adenovirus in-
fection in HIV patients who are students is attributed to
the fact that in this part of the world majority are of
school aged and often adequately monitored to ensure
that they are in their classrooms as and when due. They
are therefore less prone to daily tasks that are associated
with high rate of exposure.
Location of residence revealed a slightly higher preva-
lence (39%) of the adenovirus infection in the patients
who are urban settlers as opposed to what was noticed in
patients from the rural areas (33%). This could be as a re-
sult of exposure to variety of activities in the urban areas
which majorly are social, industrial and environmental in
nature. A research conducted in New Zealand [25] re-
ported that Human Adenovirus (HAdV) species C and F,
and Norovirus GI and GII were frequently detected in
municipal sewage and biosolid samples. It was further
stated that viruses targeted by the research study - virus
tool box (VTB) were detected in high concentrations in
municipal raw sewage, biosolids, abattoir wastes, faecally
contaminated environmental samples and also in human
and animal faecal specimens. It was also pointed out that
in New Zealand, many abattoirs discharge into municipal
sewage treatment plants, and almost all of these plants are
in close proximity to farming activities. Economic factors
could also result to the high prevalence in the urban set-
tlers as a result of Rural–urban migration, and hence lead-
ing to overcrowding in these cities.
History of recent occurrence of respiratory tract infec-
tions/conjunctivitis as a risk factor to Adenovirus co-
infection, revealed that the population of patients with
RTI’s alone far outweighed the population of patients with
RTI and Conjunctivitis. There was however, a logical
correlation between the occurrence of RTI/Conjunctiv-
itis and Adenovirus co-infections with HIV in the pa-
tients (12.5%). A case report in Eket Coastal town [26],
revealed a link between a history of antecedent upper
respiratory tract infection or close contact with a “red
eye” and adenovirus.
The possible risk factors as enumerated in the result
included the closeness of patient’s residence to livestocksettlement, which showed a prevalence rate of 50% for
each group of patients which does not indicate any tan-
gible relatedness to the prevalence of adenovirus infec-
tion in patients. However, this also does not bring about
any indication towards zoonotic transmission of Adeno-
virus to humans, thereby suggesting host specificity in
Adenovirus genera. Also, the average hours of patient’s
daily exposure to infectivity showed highest prevalence
in the age bracket 28–39 years for both 5–8 hours and
9–14 hours of exposure groups. This could be due to
the social, occupational and behavioural involvements in
day-to-day activities in this group of people. This is in
consonance with the findings of Howieson and Hogan in
2005 on early winter deaths in Scotland [27].
Patients on Antiretroviral Therapy were found to have
a slightly lower prevalence of Adenovirus infection com-
pared to the Non - ART patients. The difference could
be said to be negligible. It has been reported elsewhere
that the demonstration of massive, rapid and largely irre-
versible HIV-mediated destruction of memory CD4+ T
Cells predominantly occurring in the gut is suggestive
that primary HIV infection maybe the only time that
intervention could confer lasting immunological benefit
[28] However, there was significant difference between
the ART status of HIV patients and Adenovirus co-
infections (p < 0.05). This supports the work done by
Ghez et al., in 2000, where after 2 weeks of previous cycle
of administering chemotherapy to an HIV patient for
Burkitt lymphoma, Adenovirus-associated hemorrhagic
cystitis was reported in the patient [29]. Nevertheless,
vaccination still staggeringly stands out as a major way
of preventing Adenovirus co-infections in human popu-
lations, especially in imunocompromised patients such
as the HIV/AIDS patients.
There are several limitations regarding this study. Spe-
cific IgM antibodies have not been determined, hence
discrimination between past or present infection cannot
be ascertained. Only a subset of potential socioeconomic
risk factors as well as other potential environmental risk
factors were evaluated. The CD4 counts of the patients
were not evaluated since subject recruited were those
with confirmed HIV status based on their clinical records.
The clinical manifestations of the co-infected patients was
not elaborated. Also, the study did not differentiate and
compare the prevalence of adenovirus in HIV patients
with those with disease progression to AIDS. However,
these limitations are being addressed in an on going study
in our group.
Conclusion
In summary, the prevalence rate of Adenovirus Respira-
tory tract infection in HIV patients obtained from this
research is steadily alarming and higher than in most of
the reported studies in Nigeria and some parts of Africa.
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conducted on enteric adenovirus among Children in
Lagos and in the Northern Nigeria. Another was a case
report in Eket, Nigeria on clinical features of Epidemic
Adenovirus Ocular infection. Adenovirus infections and
co-infections in immunocompromised patients could be
aggravated by synergistic effects of the various factors
examined in this research work, hence the reduction in
the workforce of this society and also low output of in-
fected individuals in this group may be inevitable if urgent
response is not directed towards the disease control.
Children within the school age should be adequately
taken care of in regions of high prevalence especially in
arid and semi-arid regions. Children with symptomatic
manifestations suggestive of adenovirus infection should
be separated in day-care centres, and taken care of till they
are considered fit to resume normal school activities.
There are possibilities of health workers acquiring
nosocomial infections; therefore there is need for the
use of protective coverings such as gloves, nose masks
and laboratory/ward coats. Sterilization and other stand-
ard laboratory and operational practices essential in the
day-to-day running of the laboratory and hospitals,
should not be neglected and underrated. The develop-
ment of vaccines against Adenovirus holds a promise to
prevention of Adenovirus infection in individuals with
high risk of infectivity, such as the Artesans as revealed
in this study. Some Public workers (like military and
paramilitary personnel) whose occupation require tedi-
ous engagement in activities conducted under harsh en-
vironmental conditions, should however be vaccinated
during recruitment.
Governments and International Organisations should
make adequate provisions in terms of funding and sup-
port for research into the gene therapy which is focused
at modification of the Adenoviral fibre protein in target-
ing different cell lines, and hence its application in the
treatment of diseases.
Additional file
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